CD86 and neoplasm: The 4T1 tumor cryosections from different treatment groups underwent immunofluorescence staining with CD86 and CD206 antibodies, which are predominantly expressed in M1-like TAMs and M2-like TAMs populations, respectively (Figure 4A).